Anika Therapeutics
ANIK
#7626
Rank
$0.25 B
Marketcap
$17.26
Share price
0.17%
Change (1 day)
-13.79%
Change (1 year)
Categories

P/E ratio for Anika Therapeutics (ANIK)

P/E ratio as of November 2024 (TTM): -11.3

According to Anika Therapeutics's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -11.281. At the end of 2022 the company had a P/E ratio of -28.7.

P/E ratio history for Anika Therapeutics from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-28.7-123.26%
2021124-558.61%
2020-26.9-200.28%
201926.93.91%
201825.94.55%
201724.712.13%
201622.119.05%
201518.519.13%
201415.5-38.88%
201325.4125.22%
201211.3-25.08%
201115.1-23.15%
201019.6-17.72%
200923.8158.83%
20089.21-65.81%
200726.9-14.72%
200631.654.06%
200520.5121.9%
20049.24-92.41%
2003122-3912.37%
2002-3.19117.16%
2001-1.47

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
32.3-385.88%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
55.2-589.38%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
11.0-197.84%๐Ÿ‡บ๐Ÿ‡ธ USA
35.0-410.66%๐Ÿ‡บ๐Ÿ‡ธ USA
70.5-724.52%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.